Hypoparathyroidism.
Bilezikian JP.
J Clin Endocrinol Metab. 2020 Jun 1;105(6):1722-36. doi: 10.1210/clinem/dgaa113.
Hypoparathyroidism.
Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM.
Nat Rev Dis Primers. 2017 Aug 31;3:17055. doi: 10.1038/nrdp.2017.55.
Epidemiology and Diagnosis of Hypoparathyroidism.
Clarke BL, Brown EM, Collins MT, Jüppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV.
J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99. doi: 10.1210/jc.2015-3908. Epub 2016 Mar 4.
Hypoparathyroidism: Genetics and Diagnosis.
Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV, Xia W, Brandi ML.
J Bone Miner Res. 2022 Dec;37(12):2615-2629. doi: 10.1002/jbmr.4667. Epub 2022 Nov 14.
Hypoparathyroidism update.
Chiang C.
Curr Opin Endocrinol Diabetes Obes. 2024 Aug 1;31(4):164-169. doi: 10.1097/MED.0000000000000868. Epub 2024 May 16.
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L.
Autoimmun Rev. 2022 Aug;21(8):103135. doi: 10.1016/j.autrev.2022.103135. Epub 2022 Jun 9.
Skeletal Manifestations of Autoimmune Hypoparathyroidism.
Slouma M, Miri S, Metoui L, Dhahri R, Gharsallah I, Louzir B.
J Clin Rheumatol. 2021 Aug 1;27(5):e168-e169. doi: 10.1097/RHU.0000000000001307.
Hypoparathyroidism.
Hakami Y, Khan A.
Front Horm Res. 2019;51:109-126. doi: 10.1159/000491042. Epub 2018 Nov 19.
22q11.2 deletion syndrome.
McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, Scambler PJ, Bassett AS.
Nat Rev Dis Primers. 2015 Nov 19;1:15071. doi: 10.1038/nrdp.2015.71.
Hypoparathyroidism: diagnosis, management and emerging therapies.
Khan S, Khan AA.
Nat Rev Endocrinol. 2025 Jun;21(6):360-374. doi: 10.1038/s41574-024-01075-8. Epub 2025 Feb 4.
